BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20581102)

  • 1. Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice.
    Steed MM; Tyagi N; Sen U; Schuschke DA; Joshua IG; Tyagi SC
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L301-11. PubMed ID: 20581102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenteric vascular remodeling in hyperhomocysteinemia.
    Munjal C; Givvimani S; Qipshidze N; Tyagi N; Falcone JC; Tyagi SC
    Mol Cell Biochem; 2011 Feb; 348(1-2):99-108. PubMed ID: 21076854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
    Kundu S; Kumar M; Sen U; Mishra PK; Tyagi N; Metreveli N; Lominadze D; Rodriguez W; Tyagi SC
    J Cell Biochem; 2009 Jan; 106(1):119-26. PubMed ID: 19021146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
    Steed MM; Tyagi SC
    Antioxid Redox Signal; 2011 Oct; 15(7):1927-43. PubMed ID: 21126196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
    Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
    J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
    Kumar M; Tyagi N; Moshal KS; Sen U; Kundu S; Mishra PK; Givvimani S; Tyagi SC
    Neurochem Int; 2008 Dec; 53(6-8):214-9. PubMed ID: 18725259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia.
    Shastry S; Moning L; Tyagi N; Steed M; Tyagi SC
    J Cell Physiol; 2005 Dec; 205(3):422-7. PubMed ID: 15895389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
    Ovechkin AV; Tyagi N; Sen U; Lominadze D; Steed MM; Moshal KS; Tyagi SC
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L905-11. PubMed ID: 16815886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.
    Sen U; Tyagi N; Kumar M; Moshal KS; Rodriguez WE; Tyagi SC
    Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1779-87. PubMed ID: 17855772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia decreases intestinal motility leading to constipation.
    Givvimani S; Munjal C; Narayanan N; Aqil F; Tyagi G; Metreveli N; Tyagi SC
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G281-90. PubMed ID: 22595990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative remodeling in pressure overload induced chronic heart failure.
    Henderson BC; Tyagi N; Ovechkin A; Kartha GK; Moshal KS; Tyagi SC
    Eur J Heart Fail; 2007 May; 9(5):450-7. PubMed ID: 17306621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.
    Narayanan N; Pushpakumar SB; Givvimani S; Kundu S; Metreveli N; James D; Bratcher AP; Tyagi SC
    FASEB J; 2014 Aug; 28(8):3411-22. PubMed ID: 24739303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.
    Basu P; Qipshidze N; Sen U; Givvimani S; Munjal C; Mishra PK; Tyagi SC
    Arch Physiol Biochem; 2011 Dec; 117(5):270-82. PubMed ID: 21838575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of oxidative stress by homocyst(e)ine impairs endothelial function.
    Mujumdar VS; Aru GM; Tyagi SC
    J Cell Biochem; 2001; 82(3):491-500. PubMed ID: 11500925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
    Pushpakumar SB; Kundu S; Metreveli N; Sen U
    PLoS One; 2013; 8(12):e83813. PubMed ID: 24386282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
    Cheng Z; Jiang X; Pansuria M; Fang P; Mai J; Mallilankaraman K; Gandhirajan RK; Eguchi S; Scalia R; Madesh M; Yang X; Wang H
    Diabetes; 2015 Mar; 64(3):947-59. PubMed ID: 25352635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
    World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia.
    Ellis EA; Sengupta N; Caballero S; Guthrie SM; Mames RN; Grant MB
    Antioxid Redox Signal; 2005; 7(11-12):1413-22. PubMed ID: 16356104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.
    Tyagi N; Qipshidze N; Sen U; Rodriguez W; Ovechkin A; Tyagi SC
    Int J Physiol Pathophysiol Pharmacol; 2011 Sep; 3(3):210-22. PubMed ID: 21941612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-2 knockdown blunts age-dependent carotid stiffness by decreasing elastin degradation and augmenting eNOS activation.
    Diaz-Canestro C; Puspitasari YM; Liberale L; Guzik TJ; Flammer AJ; Bonetti NR; Wüst P; Costantino S; Paneni F; Akhmedov A; Varga Z; Ministrini S; Beer JH; Ruschitzka F; Hermann M; Lüscher TF; Sudano I; Camici GG
    Cardiovasc Res; 2022 Jul; 118(10):2385-2396. PubMed ID: 34586381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.